Biolytica

Central African Republic
Bayanga, Sangha-Mbaéré, Central African Republic, 6300

Company profile

Biolytica company profile

The Biolytica NEXUS platform is the first fully integrated tool to enable prevention-focused clinicians and longevity professionals to create hyper-personalized, data-driven, health optimization journeys for their clients. NEXUS is the only tool in the market that allows for the integration, visualization, correlation and analysis of data from genomics, epigenetics, digital and physical biomarkers, nutrition / lifestyle information, questionnaires and various other datapoints, allowing clinicians to not only be more precise in their health interventions, but to also track and monitor progress, create personalized action plans and stay in touch with clients, allowing them to lower churn rate of their offerings and open new revenue potentials through additional service models.

Business identity

Contact email
[email protected]
Phone number
+41 (0)41 515 5454
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2021-10-08

Headquarters

Postal code
6300
Country code
CF
Continent
Africa

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$5.9M
Last funding
Seed / $5.9M / 2023-05-02
Last equity funding
Seed / $5.9M
Investors
1
Lead investors
1
Founders
2
Articles
5

Founders and investors

Founders

Dr. Rob Konrad MaciejewskiMarc P. Bernegger

Lead investors

Maximon

Investors

Maximon